{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:53:06Z","timestamp":1791334386644,"version":"4.3.1"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T00:00:00Z","timestamp":1783641600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:00:00Z","timestamp":1791331200000},"content-version":"vor","delay-in-days":89,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"National High Level Hospital Clinical Research Funding","award":["2023IR35"],"award-info":[{"award-number":["2023IR35"]}]},{"name":"National Key Research and Development Program of China","award":["2021YFC2500600\/2021YFC2500601"],"award-info":[{"award-number":["2021YFC2500600\/2021YFC2500601"]}]},{"name":"State Key Laboratory of Vascular Homeostasis and Remodeling, Peking University","award":["National High Level Hospital Clinical Research Funding"],"award-info":[{"award-number":["National High Level Hospital Clinical Research Funding"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"DOI":"10.1186\/s12876-026-05037-4","type":"journal-article","created":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T14:25:39Z","timestamp":1783693539000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Impact of fecal microbiota transplantation on lipid parameters in patients with metabolic syndrome: a meta-analysis"],"prefix":"10.1186","volume":"26","author":[{"given":"Leyi","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangfang","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Long","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianping","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,10]]},"reference":[{"issue":"4","key":"5037_CR1","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1097\/01.hjh.0000217840.26971.b6","volume":"24","author":"PA Sarafidis","year":"2006","unstructured":"Sarafidis PA, Nilsson PM. The metabolic syndrome: a glance at its history. J Hypertens. 2006;24(4):621\u20136.","journal-title":"J Hypertens"},{"issue":"5","key":"5037_CR2","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1038\/s41574-019-0176-8","volume":"15","author":"M Bl\u00fcher","year":"2019","unstructured":"Bl\u00fcher M. Obesity: global epidemiology and pathogenesis. Nat Rev Endocrionol. 2019;15(5):288\u201398.","journal-title":"Nat Rev Endocrionol"},{"issue":"10","key":"5037_CR3","doi-asserted-by":"publisher","first-page":"3978","DOI":"10.1172\/JCI129186","volume":"129","author":"GI Smith","year":"2019","unstructured":"Smith GI, Mittendorfer B, Klein S. Metabolically healthy obesity: facts and fantasies. J Clin Investig. 2019;129(10):3978\u201389.","journal-title":"J Clin Investig"},{"key":"5037_CR4","doi-asserted-by":"publisher","DOI":"10.3390\/healthcare10091616","author":"M Yang","year":"2022","unstructured":"Yang M, Liu S, Zhang C. The related metabolic diseases and treatments of obesity. Healthcare (Basel). 2022. https:\/\/doi.org\/10.3390\/healthcare10091616.","journal-title":"Healthcare (Basel)"},{"issue":"1","key":"5037_CR5","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.gtc.2016.09.012","volume":"46","author":"SM Vindigni","year":"2017","unstructured":"Vindigni SM, Surawicz CM. Fecal Microbiota Transplantation. Gastroenterol Clin North Am. 2017;46(1):171\u201385.","journal-title":"Gastroenterol Clin North Am"},{"key":"5037_CR6","doi-asserted-by":"publisher","first-page":"7495","DOI":"10.2147\/IDR.S385485","volume":"15","author":"XH Guo","year":"2022","unstructured":"Guo XH, Zhu YL, Yang L, Li WJ, Du XF. The Effects of Multi-Donor Fecal Microbiota Transplantation Capsules Combined with Thalidomide on Hormone-Dependent Ulcerative Colitis. Infect Drug Resist. 2022;15:7495\u2013501.","journal-title":"Infect Drug Resist"},{"issue":"1","key":"5037_CR7","doi-asserted-by":"publisher","first-page":"5821","DOI":"10.1038\/s41598-019-42183-0","volume":"9","author":"DW Kang","year":"2019","unstructured":"Kang DW, Adams JB, Coleman DM, Pollard EL, Maldonado J, McDonough-Means S, et al. Long-term benefit of Microbiota Transfer Therapy on autism symptoms and gut microbiota. Sci Rep. 2019;9(1):5821.","journal-title":"Sci Rep"},{"issue":"3","key":"5037_CR8","doi-asserted-by":"publisher","first-page":"E88","DOI":"10.1002\/ajh.26077","volume":"96","author":"J Bilinski","year":"2021","unstructured":"Bilinski J, Lis K, Tomaszewska A, Grzesiowski P, Dzieciatkowski T, Tyszka M, et al. Fecal microbiota transplantation in patients with acute and chronic graft-versus-host disease-spectrum of responses and safety profile. Results from a prospective, multicenter study. Am J Hematol. 2021;96(3):E88-e91.","journal-title":"Am J Hematol"},{"issue":"7","key":"5037_CR9","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1093\/cid\/cix1085","volume":"66","author":"LC McDonald","year":"2018","unstructured":"McDonald LC, Gerding DN, Johnson S, Bakken JS, Carroll KC, Coffin SE, et al. Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA). Clin Infect Dis. 2018;66(7):e1\u201348.","journal-title":"Clin Infect Dis"},{"issue":"6","key":"5037_CR10","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.14309\/ajg.0000000000001278","volume":"116","author":"CR Kelly","year":"2021","unstructured":"Kelly CR, Fischer M, Allegretti JR, LaPlante K, Stewart DB, Limketkai BN, et al. ACG Clinical Guidelines: Prevention, Diagnosis, and Treatment of Clostridioides difficile Infections. Am J Gastroenterol. 2021;116(6):1124\u201347.","journal-title":"Am J Gastroenterol"},{"key":"5037_CR11","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.","journal-title":"BMJ"},{"issue":"4","key":"5037_CR12","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1136\/gutjnl-2020-323617","volume":"71","author":"SC Ng","year":"2022","unstructured":"Ng SC, Xu Z, Mak JWY, Yang K, Liu Q, Zuo T, et al. Microbiota engraftment after faecal microbiota transplantation in obese subjects with type 2 diabetes: a 24-week, double-blind, randomised controlled trial. Gut. 2022;71(4):716\u201323.","journal-title":"Gut"},{"key":"5037_CR13","doi-asserted-by":"crossref","unstructured":"Ghorbani Y, Schwenger KJ, Sharma D, Jung H, Yadav J, Xu W, et al. Effect of Fecal Microbial Transplant via colonoscopy in patients with severe obesity and insulin resistance: a randomized double-blind, placebo-controlled phase 2 trial. Diabetes Obes Metab. 2022.","DOI":"10.1111\/dom.14891"},{"issue":"1","key":"5037_CR14","doi-asserted-by":"publisher","first-page":"1993513","DOI":"10.1080\/19490976.2021.1993513","volume":"13","author":"EWJ van der Vossen","year":"2021","unstructured":"van der Vossen EWJ, Bastos D, Stols-Gon\u00e7alves D, de Goffau MC, Davids M, Pereira JPB, et al. Effects of fecal microbiota transplant on DNA methylation in subjects with metabolic syndrome. Gut Microbes. 2021;13(1):1993513.","journal-title":"Gut Microbes"},{"key":"5037_CR15","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2021.662159","author":"AM Koopen","year":"2021","unstructured":"Koopen AM, Almeida EL, Attaye I, Witjes JJ, Rampanelli E, Majait S, et al. Effect of fecal microbiota transplantation combined with Mediterranean diet on insulin sensitivity in subjects with metabolic syndrome. Front Microbiol. 2021. https:\/\/doi.org\/10.3389\/fmicb.2021.662159.","journal-title":"Front Microbiol"},{"issue":"3","key":"5037_CR16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1003051","volume":"17","author":"EW Yu","year":"2020","unstructured":"Yu EW, Gao L, Stastka P, Cheney MC, Mahabamunuge J, Torres Soto M, et al. Fecal microbiota transplantation for the improvement of metabolism in obesity: the FMT-TRIM double-blind placebo-controlled pilot trial. PLoS Med. 2020;17(3):e1003051.","journal-title":"PLoS Med"},{"key":"5037_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2020.101076","volume":"42","author":"AV Hartstra","year":"2020","unstructured":"Hartstra AV, Sch\u00fcppel V, Imangaliyev S, Schrantee A, Prodan A, Collard D, et al. Infusion of donor feces affects the gut-brain axis in humans with metabolic syndrome. Mol Metab. 2020;42:101076.","journal-title":"Mol Metab"},{"key":"5037_CR18","doi-asserted-by":"crossref","unstructured":"Smits LP, Kootte RS, Levin E, Prodan A, Fuentes S, Zoetendal EG, et al. Effect of Vegan Fecal Microbiota Transplantation on Carnitine- and Choline-Derived Trimethylamine-N-Oxide Production and Vascular Inflammation in Patients With Metabolic Syndrome. J Am Heart Assoc. 2018;7(7).","DOI":"10.1161\/JAHA.117.008342"},{"issue":"4","key":"5037_CR19","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/j.cmet.2017.09.008","volume":"26","author":"RS Kootte","year":"2017","unstructured":"Kootte RS, Levin E, Salojarvi J, Smits LP, Hartstra AV, Udayappan SD, et al. Improvement of insulin sensitivity after lean donor feces in metabolic syndrome is driven by baseline intestinal microbiota composition. Cell Metab. 2017;26(4):611.","journal-title":"Cell Metab"},{"issue":"4","key":"5037_CR20","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1053\/j.gastro.2012.06.031","volume":"143","author":"A Vrieze","year":"2012","unstructured":"Vrieze A, Van Nood E, Holleman F, Saloj\u00e4rvi J, Kootte RS, Bartelsman JF, et al. Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome. Gastroenterology. 2012;143(4):913-6.e7.","journal-title":"Gastroenterology"},{"key":"5037_CR21","unstructured":"Review Manager (RevMan) 5.4.1."},{"issue":"1","key":"5037_CR22","doi-asserted-by":"publisher","first-page":"22378","DOI":"10.1038\/s41598-022-26759-x","volume":"12","author":"K St\u00f8","year":"2022","unstructured":"St\u00f8 K, Valeur J, Ueland T, Malmstr\u00f8m GH, Bjerkeli V, Tr\u00f8seid M, et al. Fecal level of butyric acid, a microbiome-derived metabolite, is increased in patients with severe carotid atherosclerosis. Sci Rep. 2022;12(1):22378.","journal-title":"Sci Rep"},{"issue":"5","key":"5037_CR23","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1038\/s41569-022-00686-w","volume":"19","author":"GB Lim","year":"2022","unstructured":"Lim GB. Changes to the gut microbiota drive the progression of cardiometabolic disease. Nat Rev Cardiol. 2022;19(5):283.","journal-title":"Nat Rev Cardiol"},{"issue":"4","key":"5037_CR24","doi-asserted-by":"publisher","first-page":"E511","DOI":"10.1152\/ajpendo.00471.2017","volume":"315","author":"TT Kim","year":"2018","unstructured":"Kim TT, Parajuli N, Sung MM, Bairwa SC, Levasseur J, Soltys CLM, et al. Fecal transplant from resveratrol-fed donors improves glycaemia and cardiovascular features of the metabolic syndrome in mice. Am J Physiol Endocrinol Metab. 2018;315(4):E511\u20139.","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"8","key":"5037_CR25","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.2337\/db17-1488","volume":"67","author":"C Bidu","year":"2018","unstructured":"Bidu C, Escoula Q, Bellenger S, Spor A, Galan M, Geissler A, et al. The transplantation of \u03c93 PUFA-altered gut microbiota of fat-1 mice to wild-type littermates prevents obesity and associated metabolic disorders. Diabetes. 2018;67(8):1512\u201323.","journal-title":"Diabetes"},{"key":"5037_CR26","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph14060555","author":"JH Wang","year":"2017","unstructured":"Wang JH, Kim BS, Han K, Kim H. Ephedra-treated donor-derived gut microbiota transplantation ameliorates high fat diet-induced obesity in rats. Int J Environ Res Public Health. 2017. https:\/\/doi.org\/10.3390\/ijerph14060555.","journal-title":"Int J Environ Res Public Health"},{"issue":"1","key":"5037_CR27","first-page":"79","volume":"2","author":"D Porras","year":"2017","unstructured":"Porras D, Nistal E, Mart\u00ednez-Fl\u00f3rez S, Jorquera F, Olcoz JL, Jover R, et al. Metabolic phenotype transfer through gut microbiota transplantation from HFD-FED and quercetin treated donors modulates obesity-related NAFLD in germ-free mice. Inflammatory Intestinal Diseases. 2017;2(1):79.","journal-title":"Inflammatory Intestinal Diseases"},{"issue":"1","key":"5037_CR28","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s12986-016-0116-8","volume":"13","author":"M Kulecka","year":"2016","unstructured":"Kulecka M, Paziewska A, Zeber-Lubecka N, Ambrozkiewicz F, Kopczynski M, Kuklinska U, et al. Prolonged transfer of feces from the lean mice modulates gut microbiota in obese mice. Nutr Metab (Lond). 2016;13(1):57.","journal-title":"Nutr Metab (Lond)"},{"issue":"8","key":"5037_CR29","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0134893","volume":"10","author":"B Di Luccia","year":"2015","unstructured":"Di Luccia B, Crescenzo R, Mazzoli A, Cigliano L, Venditti P, Walser JC, et al. Rescue of fructose-induced metabolic syndrome by antibiotics or faecal transplantation in a rat model of obesity. PLoS ONE. 2015;10(8):e0134893.","journal-title":"PLoS ONE"},{"key":"5037_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2023.110803","volume":"202","author":"L Zecheng","year":"2023","unstructured":"Zecheng L, Donghai L, Runchuan G, Yuan Q, Qi J, Yijia Z, et al. Fecal microbiota transplantation in obesity metabolism: a meta analysis and systematic review. Diabetes Res Clin Pract. 2023;202:110803.","journal-title":"Diabetes Res Clin Pract"},{"issue":"7","key":"5037_CR31","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0288718","volume":"18","author":"B Qiu","year":"2023","unstructured":"Qiu B, Liang J, Li C. Effects of fecal microbiota transplantation in metabolic syndrome: A meta-analysis of randomized controlled trials. PLoS ONE. 2023;18(7):e0288718.","journal-title":"PLoS ONE"},{"key":"5037_CR32","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2021.775216","volume":"8","author":"B Pan","year":"2021","unstructured":"Pan B, Liu X, Shi J, Chen Y, Xu Z, Shi D, et al. A Meta-Analysis of Microbial Therapy Against Metabolic Syndrome: Evidence From Randomized Controlled Trials. Front Nutr. 2021;8:775216.","journal-title":"Front Nutr"},{"key":"5037_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.nutres.2020.06.018","volume":"83","author":"IM Proen\u00e7a","year":"2020","unstructured":"Proen\u00e7a IM, Allegretti JR, Bernardo WM, de Moura DTH, Ponte Neto AM, Matsubayashi CO, et al. Fecal microbiota transplantation improves metabolic syndrome parameters: systematic review with meta-analysis based on randomized clinical trials. Nutr Res. 2020;83:1\u201314.","journal-title":"Nutr Res"},{"key":"5037_CR34","doi-asserted-by":"publisher","DOI":"10.3390\/nu11102291","author":"Z Zhang","year":"2019","unstructured":"Zhang Z, Mocanu V, Cai C, Dang J, Slater L, Deehan EC, et al. Impact of fecal microbiota transplantation on obesity and metabolic syndrome-a systematic review. Nutrients. 2019. https:\/\/doi.org\/10.3390\/nu11102291.","journal-title":"Nutrients"},{"key":"5037_CR35","doi-asserted-by":"publisher","DOI":"10.1002\/hep4.1601","author":"JJ Witjes","year":"2020","unstructured":"Witjes JJ, Smits LP, Pekmez CT, Prodan A, Meijnikman AS, Troelstra MA, et al. Donor fecal microbiota transplantation alters gut microbiota and metabolites in obese individuals with steatohepatitis. Hepatol Commun. 2020. https:\/\/doi.org\/10.1002\/hep4.1601.","journal-title":"Hepatol Commun"},{"issue":"4","key":"5037_CR36","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1016\/j.cgh.2019.07.006","volume":"18","author":"JR Allegretti","year":"2020","unstructured":"Allegretti JR, Kassam Z, Mullish BH, Chiang A, Carrellas M, Hurtado J, et al. Effects of fecal microbiota transplantation with oral capsules in obese patients. Clin Gastroenterol Hepatol. 2020;18(4):855-63.e2.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"5037_CR37","doi-asserted-by":"crossref","unstructured":"Su LL, Hong ZF, Zhou T, Jian YY, Xu M, Zhang XP, et al. Health improvements of type 2 diabetic patients through diet and diet plus fecal microbiota transplantation. SCIENTIFIC REPORTS. 2022;12(1).","DOI":"10.1038\/s41598-022-05127-9"},{"issue":"12","key":"5037_CR38","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.30415","volume":"3","author":"KSW Leong","year":"2020","unstructured":"Leong KSW, Jayasinghe TN, Wilson BC, Derraik JGB, Albert BB, Chiavaroli V, et al. Effects of Fecal Microbiome Transfer in Adolescents With Obesity: the Gut Bugs Randomized Controlled Trial. JAMA Netw Open. 2020;3(12):e2030415.","journal-title":"JAMA Netw Open"},{"issue":"7","key":"5037_CR39","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1038\/s41591-021-01399-2","volume":"27","author":"V Mocanu","year":"2021","unstructured":"Mocanu V, Zhang Z, Deehan EC, Kao DH, Hotte N, Karmali S, et al. Fecal microbial transplantation and fiber supplementation in patients with severe obesity and metabolic syndrome: a randomized double-blind, placebo-controlled phase 2 trial. Nat Med. 2021;27(7):1272\u20139.","journal-title":"Nat Med"},{"issue":"7","key":"5037_CR40","doi-asserted-by":"publisher","first-page":"660","DOI":"10.5551\/jat.RV17006","volume":"24","author":"H Ohira","year":"2017","unstructured":"Ohira H, Tsutsui W, Fujioka Y. Are Short Chain Fatty Acids in Gut Microbiota Defensive Players for Inflammation and Atherosclerosis? J Atheroscler Thromb. 2017;24(7):660\u201372.","journal-title":"J Atheroscler Thromb"},{"issue":"1","key":"5037_CR41","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1186\/s40168-023-01709-5","volume":"11","author":"H Xu","year":"2023","unstructured":"Xu H, Fang F, Wu K, Song J, Li Y, Lu X, et al. Gut microbiota-bile acid crosstalk regulates murine lipid metabolism via the intestinal FXR-FGF19 axis in diet-induced humanized dyslipidemia. Microbiome. 2023;11(1):262.","journal-title":"Microbiome"},{"issue":"1","key":"5037_CR42","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1017\/S0007114516001045","volume":"116","author":"M Candela","year":"2016","unstructured":"Candela M, Biagi E, Soverini M, Consolandi C, Quercia S, Severgnini M, et al. Modulation of gut microbiota dysbioses in type 2 diabetic patients by macrobiotic Ma-Pi 2 diet. Br J Nutr. 2016;116(1):80\u201393.","journal-title":"Br J Nutr"},{"issue":"22","key":"5037_CR43","doi-asserted-by":"publisher","first-page":"2486","DOI":"10.1161\/CIRCULATIONAHA.118.033714","volume":"138","author":"N Yoshida","year":"2018","unstructured":"Yoshida N, Emoto T, Yamashita T, Watanabe H, Hayashi T, Tabata T, et al. Bacteroides vulgatus and Bacteroides dorei Reduce Gut Microbial Lipopolysaccharide Production and Inhibit Atherosclerosis. Circulation. 2018;138(22):2486\u201398.","journal-title":"Circulation"},{"issue":"11","key":"5037_CR44","doi-asserted-by":"publisher","first-page":"1744","DOI":"10.1136\/gutjnl-2014-307913","volume":"64","author":"ES Chambers","year":"2015","unstructured":"Chambers ES, Viardot A, Psichas A, Morrison DJ, Murphy KG, Zac-Varghese SE, et al. Effects of targeted delivery of propionate to the human colon on appetite regulation, body weight maintenance and adiposity in overweight adults. Gut. 2015;64(11):1744\u201354.","journal-title":"Gut"},{"issue":"1","key":"5037_CR45","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/nrendo.2016.150","volume":"13","author":"SO Fetissov","year":"2017","unstructured":"Fetissov SO. Role of the gut microbiota in host appetite control: bacterial growth to animal feeding behaviour. Nat Rev Endocrinol. 2017;13(1):11\u201325.","journal-title":"Nat Rev Endocrinol"},{"key":"5037_CR46","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.anaerobe.2016.10.011","volume":"42","author":"RA Yunes","year":"2016","unstructured":"Yunes RA, Poluektova EU, Dyachkova MS, Klimina KM, Kovtun AS, Averina OV, et al. GABA production and structure of gadB\/gadC genes in Lactobacillus and Bifidobacterium strains from human microbiota. Anaerobe. 2016;42:197\u2013204.","journal-title":"Anaerobe"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12876-026-05037-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-026-05037-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-026-05037-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:26:46Z","timestamp":1791332806000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12876-026-05037-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,10]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5037"],"URL":"https:\/\/doi.org\/10.1186\/s12876-026-05037-4","relation":{},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,10]]},"assertion":[{"value":"14 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study is a meta-analysis based entirely on previously published data. As no new human or animal participants were recruited or directly involved, ethical approval and informed consent were not required. We relied on the ethical approvals and informed consent procedures reported in the included trials, which were conducted in accordance with their institutional review board (IRB) requirements and relevant ethical standards (e.g., the Declaration of Helsinki). No identifiable individual-level data were accessed. The study protocol was registered in PROSPERO (CRD42023389890).","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"617"}}